| Literature DB >> 26713674 |
Fernando López1,2, Juan P Rodrigo1,2, Carl E Silver3, Missak Haigentz4, Justin A Bishop5, Primož Strojan6, Dana M Hartl7,8, Patrick J Bradley9, William M Mendenhall10, Carlos Suárez2, Robert P Takes11, Marc Hamoir12, K Thomas Robbins13, Ashok R Shaha14, Jochen A Werner15, Alessandra Rinaldo16, Alfio Ferlito17.
Abstract
Although most malignant lymphadenopathy in the neck represent lymphomas or metastases from head and neck primary tumors, occasionally, metastatic disease from remote, usually infraclavicular, sites presents as cervical lymphadenopathy with or without an obvious primary tumor. In general, these tumors metastasize to supraclavicular lymph nodes, but occasionally may present at an isolated higher neck level. A search for the primary tumor includes information gained by histology, immunohistochemistry, and evaluation of molecular markers that may be unique to the primary tumor site. In addition, 18F-fluoro-2-deoxyglocose positron emission tomography combined with CT (FDG-PET/CT) has greatly improved the ability to detect the location of an unknown primary tumor, particularly when in a remote location. Although cervical metastatic disease from a remote primary site is often incurable, there are situations in which meaningful survival can be achieved with appropriate local treatment. Management is quite complex and requires a truly multidisciplinary approach.Entities:
Keywords: cervical lymph node; diagnosis; neck dissection; non-head and neck cancer; unknown primary
Mesh:
Substances:
Year: 2015 PMID: 26713674 PMCID: PMC4991634 DOI: 10.1002/hed.24344
Source DB: PubMed Journal: Head Neck ISSN: 1043-3074 Impact factor: 3.147